- Home
- ARTNA vs ATXS Comparison
ARTNA vs ATXS Comparison
Compare ARTNA & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTNA
- ATXS
- Stock Information
- Founded
- ARTNA 1905
- ATXS 2008
- Country
- ARTNA United States
- ATXS United States
- Employees
- ARTNA N/A
- ATXS N/A
- Industry
- ARTNA Water Supply
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- ARTNA Utilities
- ATXS Health Care
- Exchange
- ARTNA Nasdaq
- ATXS Nasdaq
- Market Cap
- ARTNA 343.5M
- ATXS 401.2M
- IPO Year
- ARTNA 1996
- ATXS 2015
- Fundamental
- Price
- ARTNA $33.46
- ATXS $6.53
- Analyst Decision
- ARTNA
- ATXS Buy
- Analyst Count
- ARTNA 0
- ATXS 6
- Target Price
- ARTNA N/A
- ATXS $32.00
- AVG Volume (30 Days)
- ARTNA 27.3K
- ATXS 261.2K
- Earning Date
- ARTNA 08-04-2025
- ATXS 08-12-2025
- Dividend Yield
- ARTNA 3.67%
- ATXS N/A
- EPS Growth
- ARTNA 22.07
- ATXS N/A
- EPS
- ARTNA 2.17
- ATXS N/A
- Revenue
- ARTNA $110,427,000.00
- ATXS N/A
- Revenue This Year
- ARTNA $6.86
- ATXS N/A
- Revenue Next Year
- ARTNA $4.46
- ATXS N/A
- P/E Ratio
- ARTNA $15.45
- ATXS N/A
- Revenue Growth
- ARTNA 7.13
- ATXS N/A
- 52 Week Low
- ARTNA $29.45
- ATXS $3.56
- 52 Week High
- ARTNA $38.94
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- ARTNA 52.02
- ATXS 50.04
- Support Level
- ARTNA $33.00
- ATXS $6.12
- Resistance Level
- ARTNA $34.24
- ATXS $6.96
- Average True Range (ATR)
- ARTNA 0.62
- ATXS 0.42
- MACD
- ARTNA 0.02
- ATXS -0.04
- Stochastic Oscillator
- ARTNA 53.48
- ATXS 41.23
About ARTNA Artesian Resources Corporation
Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.